<unk>  is a mRNA based COVID-19 vaccine candidate being developed by Gennova Biopharmaceuticals and HDT Bio Corp. with active support from NIH under The Indo-US Vaccine Action Program (VAP) and Department of Biotechnology, India.
HGC019
IEC 62304
EPI-001
SmeT
MVA-B
Southern Cross group 
ESKAPE
ID2020